In the month since Food and Drug Administration Commissioner Marty Makary promoted the decades-old drug from GSK,
That's as far as I needed to read. GlaxoSmithKline pushed a few dollars into Marty's hands and not they get to see a spike in profit. That's all this is, another grift. Same as invermectin, same as every other drug that they promote.